These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 26965957
1. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. Dorrani M, Garbuzenko OB, Minko T, Michniak-Kohn B. J Control Release; 2016 Apr 28; 228():150-158. PubMed ID: 26965957 [Abstract] [Full Text] [Related]
3. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Kigasawa K, Kajimoto K, Hama S, Saito A, Kanamura K, Kogure K. Int J Pharm; 2010 Jan 04; 383(1-2):157-60. PubMed ID: 19732811 [Abstract] [Full Text] [Related]
5. Epidermal cell culture model with tight stratum corneum as a tool for dermal gene delivery studies. Paasonen L, Korhonen M, Yliperttula M, Urtti A. Int J Pharm; 2006 Jan 13; 307(2):188-93. PubMed ID: 16297582 [Abstract] [Full Text] [Related]
7. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array. Haigh O, Depelsenaire AC, Meliga SC, Yukiko SR, McMillan NA, Frazer IH, Kendall MA. J Control Release; 2014 Nov 28; 194():148-56. PubMed ID: 25192942 [Abstract] [Full Text] [Related]
8. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. Jose A, Labala S, Venuganti VV. J Drug Target; 2017 Apr 28; 25(4):330-341. PubMed ID: 27819148 [Abstract] [Full Text] [Related]
12. An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis. Desmet E, Bracke S, Forier K, Taevernier L, Stuart MC, De Spiegeleer B, Raemdonck K, Van Gele M, Lambert J. Int J Pharm; 2016 Mar 16; 500(1-2):268-74. PubMed ID: 26806466 [Abstract] [Full Text] [Related]
13. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes. Schlegel A, Largeau C, Bigey P, Bessodes M, Lebozec K, Scherman D, Escriou V. J Control Release; 2011 Jun 30; 152(3):393-401. PubMed ID: 21497175 [Abstract] [Full Text] [Related]
14. Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Hsu T, Mitragotri S. Proc Natl Acad Sci U S A; 2011 Sep 20; 108(38):15816-21. PubMed ID: 21903933 [Abstract] [Full Text] [Related]
15. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide. Ibaraki H, Kanazawa T, Takashima Y, Okada H, Seta Y. Molecules; 2016 Sep 24; 21(10):. PubMed ID: 27669207 [Abstract] [Full Text] [Related]
16. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA. Kawai M, Ibaraki H, Takashima Y, Kanazawa T, Okada H. Mol Pharm; 2021 Mar 01; 18(3):1038-1047. PubMed ID: 33395310 [Abstract] [Full Text] [Related]
17. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes. Jose A, Labala S, Ninave KM, Gade SK, Venuganti VVK. AAPS PharmSciTech; 2018 Jan 01; 19(1):166-175. PubMed ID: 28639178 [Abstract] [Full Text] [Related]
18. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment. Ruan W, Zhai Y, Yu K, Wu C, Xu Y. Int J Pharm; 2018 Dec 20; 553(1-2):298-309. PubMed ID: 30347273 [Abstract] [Full Text] [Related]
19. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase. Depieri LV, Borgheti-Cardoso LN, Campos PM, Otaguiri KK, Vicentini FT, Lopes LB, Fonseca MJ, Bentley MV. Eur J Pharm Biopharm; 2016 Aug 20; 105():50-8. PubMed ID: 27224855 [Abstract] [Full Text] [Related]